Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus

Clinical trial NCT05417880 · UNKNOWN

Trial details

NCT number: NCT05417880
Sponsor: Scotmann Pharmaceuticals
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2022-08-01
Primary completion: 2023-02-01
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.